Describing the mechanism of antimicrobial peptide action with the interfacial activity model
51 FujimuraM.Morita-FujimuraY.KawaseM.ChanP
Liu C-Y, Wang M, Yu H-M, Han F-X, Wu Q-S, Cai X-J, et al
Saedi and colleagues reported that CD and dementia can be caused by many factors, including AD, degenerative diseases, vascular dementia, certain types of drug abuse, depression, and anxiety, disturbed sleep, hormones, metabolic disorders, DM, alcohol abuse, Lyme disease, hippocampal sclerosis, subdual and epidural hematomas, vitamin B12 deficiency, seizures, human immunodeficiency virus (HIV)-associated neurocognitive disorder, and Hashimotos encephalopathy (Saedi et al., 2016)
Topol EJ
What the Research Says BPC-157: Evidence Overview What the Research Supports (Animal Models) The majority of BPC-157 research has been conducted in rodent models and has demonstrated: Accelerated healing of tendon, ligament, and muscle injuries Gastroprotective effects against NSAID-induced ulcers and inflammatory bowel lesions Neuroprotection in models of traumatic brain injury and peripheral nerve damage Systemic anti-inflammatory activity Bone healing support and osteoblast activity enhancement The animal research for BPC-157 is genuinely compelling in breadth
